Video: A decade of open access
What has made Nature Communications successful over the past ten years, and what to do the editors have in store for the next decade?
Published in Social Sciences
Like
Be the first to like this
Nature Communications launched in 2010 as the first online-only, hybrid journal from Nature Research. Join our anniversary celebration with a video from past and present Chief Editors.
Featuring:
- Elisa De Ranieri | Editor in Chief, Nature Communications
- Magdalena Skipper | Editor in Chief, Nature (Former Editor in Chief, Nature Communications)
- Enda Bergin | Chief Physical Sciences Editor, Nature Communications
- David Gevaux | Editorial Director, Nature Research & BMC Physical Sciences Community Journals (Former Chief Physical Sciences Editor, Nature Communications)
- Nathalie Le Bot | Chief Life Sciences Editor, Nature Communications
- Niki Scaplehorn | Editorial Director, Nature Life Science Journals (Former Chief Life Sciences Editor, Nature Communications)
Follow the Topic
Society
Humanities and Social Sciences > Society
-
Nature Communications
An open access, multidisciplinary journal dedicated to publishing high-quality research in all areas of the biological, health, physical, chemical and Earth sciences.
Related Collections
With Collections, you can get published faster and increase your visibility.
Women's Health
A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.
Publishing Model: Hybrid
Deadline: Ongoing
Tumor Microenvironment Crosstalk and Therapeutic Implications
With this cross-journal Collection, the editors at Nature Immunology, Nature Communications, Communications Medicine and Scientific Reports invite manuscripts that highlight cutting-edge research on TME crosstalk and its therapeutic implications. Topics of interest include immune modulation and checkpoint pathways, cancer-associated fibroblasts and stromal remodeling, angiogenesis and vascular normalization, metabolic reprogramming within the TME, and the role of microbiota in tumor-immune dynamics. We also welcome studies on novel therapeutic approaches that exploit TME vulnerabilities to advance cancer treatment.
Publishing Model: Hybrid
Deadline: Nov 02, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in